Literature DB >> 15301652

Why do people with delusions fail to choose more realistic explanations for their experiences? An empirical investigation.

Daniel Freeman1, Philippa A Garety, David Fowler, Elizabeth Kuipers, Paul E Bebbington, Graham Dunn.   

Abstract

Delusions can be viewed as explanations of experiences,. By definition, the experiences are insufficient to merit the delusional explanations. So why have delusions been accepted rather than more realistic explanations? The authors report a study of alternative explanations in 100 individuals with delusions. Patients were assessed on the following criteria: symptom measures, the evidence for the delusions, the availability of alternative explanations, reasoning, and self-esteem. Three quarters of the patients did not report any alternative explanation for the experiences on which the delusions were based. These patients reported significantly more internal anomalous experiences and had a more hasty reasoning style than patients who did have alternative explanations available. Having doubt in a delusion, without an alternative explanation, was associated with lower self-esteem. Clinicians will need to develop plausible and compelling alternative accounts of experience in interventions rather than merely challenge patients' delusional beliefs.

Entities:  

Mesh:

Year:  2004        PMID: 15301652     DOI: 10.1037/0022-006X.72.4.671

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  41 in total

1.  Erotomania and Recommendations for Treatment.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2016-06

Review 2.  A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations.

Authors:  Mark van der Gaag
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

3.  The multidimensional measurement of the positive symptoms of psychosis.

Authors:  Craig Steel; Philippa A Garety; Daniel Freeman; Ellen Craig; Elizabeth Kuipers; Paul Bebbington; David Fowler; Graham Dunn
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

4.  Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future study.

Authors:  Paul H Lysaker; Shirley M Glynn; Sandra M Wilkniss; Steven M Silverstein
Journal:  Psychol Serv       Date:  2010-05-01

Review 5.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

Review 6.  Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms.

Authors:  Elizabeth Kuipers; Philippa Garety; David Fowler; Daniel Freeman; Graham Dunn; Paul Bebbington
Journal:  Schizophr Bull       Date:  2006-08-02       Impact factor: 9.306

7.  Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: a computerized experience sampling study.

Authors:  Dror Ben-Zeev; Kemp Ellington; Joel Swendsen; Eric Granholm
Journal:  Schizophr Bull       Date:  2010-04-28       Impact factor: 9.306

8.  Incautious reasoning as a pathogenetic factor for the development of psychotic symptoms in schizophrenia.

Authors:  Steffen Moritz; Todd S Woodward; Daniel Hausmann
Journal:  Schizophr Bull       Date:  2005-12-09       Impact factor: 9.306

9.  Patterns of lifetime female victimisation and psychotic experiences: a study based on the UK Adult Psychiatric Morbidity Survey 2007.

Authors:  Mark Shevlin; Tara O'Neill; James E Houston; John Read; Richard P Bentall; Jamie Murphy
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-09       Impact factor: 4.328

10.  What makes one person paranoid and another person anxious? The differential prediction of social anxiety and persecutory ideation in an experimental situation.

Authors:  D Freeman; M Gittins; K Pugh; A Antley; M Slater; G Dunn
Journal:  Psychol Med       Date:  2008-06-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.